SCHEMBL31582913

SCHEMBL31582913

Cc1ccc(Br)c(F)c1C(C)O

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17434126 0.85 MEN1 (0.34) MEN1KMT2A
SCHEMBL26465636 0.83 ALDH1A1 (0.31)
SCHEMBL10324344 0.82 MEN1 (0.33) MEN1KMT2A
SCHEMBL3841835 0.78 PDE2A (0.33) MEN1KMT2A
SCHEMBL6744766 0.73 MEN1 (0.33) MEN1KMT2A
SCHEMBL17433962 0.73 ALDH1A1 (0.30)
SCHEMBL17433876 0.73 APLNR (0.31)
SCHEMBL31739098 0.72 METAP2 (0.35)
SCHEMBL24373240 0.72 MEN1 (0.32) MEN1KMT2A
SCHEMBL29478802 0.72 MEN1 (0.32) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025106644-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ALPHA-V BETA-1 INTEGRIN MORPHIC THERAPEUTIC, INC. (US) 2025-05-22 WO disclosed